-
Chronic Kidney Disease in Type-2 Diabetes Patients: A Population-Based Descriptive Study
Sep 9, 2025, 16:22 PM -
Real-World Outcomes and Economic Impact of Ribociclib in HR+/HER2- Advanced Breast Cancer: Evidence From the Portuguese REASSURE Cohort
Sep 9, 2025, 16:22 PM -
Overcoming Patient Access Barriers in Complex Conditions: Lessons From Schizophrenia for Broader Healthcare Applications
Sep 9, 2025, 16:22 PM -
Efficient and High-Quality Decision Making: An Exploration of Disease-Specific Reference Models at NICE
Sep 9, 2025, 16:22 PM -
Quantifying the Impact of Inconsistencies in Economic Modeling Assumptions: A Case Study in Metastatic Colorectal Cancer
Sep 9, 2025, 16:22 PM -
Economic Assessments of Rare Disease Drugs in France: Insights From CEESP Opinions Reviews
Sep 9, 2025, 16:22 PM -
Development of a Discrete Event Simulation Model to Explore the Potential Cost-Effectiveness for Cancer Early Detection Testing in Female BRCA Carriers
Sep 9, 2025, 16:22 PM -
HPV-Related Disease Burden in Men and Women in the Czech Republic: A Claims Database Analysis
Sep 9, 2025, 16:22 PM -
Improving Pulmonary Tuberculosis Treatment Outcomes Through Pharmacist-Led Education: Findings From a Malaysian Randomized Control Trial
Sep 9, 2025, 16:22 PM -
An Exploration of the Incidence Rate of Anxiety and Depression Following a Diagnosis of Rheumatoid Arthritis Using the THIN Dataset
Sep 9, 2025, 16:22 PM -
Stakeholder Engagement in the Economic Evaluation of Site-Specific Wastewater-Based Surveillance for Preventing COVID-19 Outbreaks in Long-Term Care Facilities
Sep 9, 2025, 16:22 PM -
Clinical Management and Outcomes of Patients in England With eGFR Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Observational Study and Its Impact on UK Health Technology Assessments
Sep 9, 2025, 16:22 PM -
Are Economic Models in R That Shiny? Making Cost-Effectiveness Models Shinier by Integrating Artificial Intelligence Applications
Sep 9, 2025, 16:22 PM -
Identifying Patient-Reported Outcome Measures to Capture Patients’ Experiences of Symptoms and Impacts of Myelodysplastic Syndromes (MDS)
Sep 9, 2025, 16:22 PM -
Targeted Literature Review Examining the Inclusion of Caregiver Costs and Quality of Life in Published Economic Models for Neurological Conditions
Sep 9, 2025, 16:22 PM -
Development and Application of a JCA-Alignment Checklist for Early Economic Modeling in EU HTA
Sep 9, 2025, 16:22 PM -
Cardioprotective Medication Use Among Diabetic Patients With ASCVD in Qatar's Primary Care Setting
Sep 9, 2025, 16:22 PM -
Establishing the Relationship Between the Worst Itch Numerical Rating Scale and EQ-5D Utility in Patients With Primary Biliary Cholangitis Experiencing Pruritus: Pooled Results From GLIMMER and the PRO Validation Study
Sep 9, 2025, 16:22 PM -
Medication Use in Indolent Systemic Mastocytosis (ISM) in Germany Prior to Avapritinib EMA Approval
Sep 9, 2025, 16:22 PM -
Comparing Individualized Treatment Effect Inference Methods Through a Simulation Study
Sep 9, 2025, 16:22 PM
